A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rivaroxaban Impurity 127 - Request Quote

Picture of Rivaroxaban Impurity 127

Rivaroxaban Impurity 127

SZ CAT No:SZ-R017199
CAS No
NA
Mol.F.
C19H18ClN3O5S
Mol.Wt.
435.9
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rivaroxaban Impurity 127 is chemically 4-(4-(((3-(5-Chlorothiophene-2-carbonyl)-2-oxooxazolidin-5-yl)methyl)amino)phenyl)morpholin-3-one. Rivaroxaban Impurity 127 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 127 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Rivaroxaban Impurity 127

Purchase Rivaroxaban Impurity 127

Rivaroxaban Impurity 127 suppliers

Rivaroxaban Impurity 127 manufacturers

Rivaroxaban Impurity 127 price

Order Rivaroxaban Impurity 127

Enquire Rivaroxaban Impurity 127

Rivaroxaban Impurity 127 cost

Rivaroxaban Impurity 127 Supplier

Rivaroxaban Impurity 127 Distributor

Rivaroxaban Impurity 127 for Method Validation

Rivaroxaban Reference Standard

Rivaroxaban Impurity 127 for ANDA Filing

Rivaroxaban Impurity 127 for Forced Degradation Studies

Rivaroxaban Impurity 127 Identification Standards

Rivaroxaban Impurity 127 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,